FeesSafety
Pluang+

RadNet to acquire ONRAD, expanding into hospital radiology with $350M cash and stock deal.

Company Fundamentals
26 Oct 2026, 23:01 WIB
GlobeNewsWire
View Source
Bullish
RadNet to acquire ONRAD, expanding into hospital radiology with $350M cash and stock deal.

RadNet, a leading outpatient diagnostic imaging provider, announced an agreement to acquire ONRAD, a teleradiology and in-hospital radiology staffing company. The deal, valued at $350 million in cash plus 5 million RadNet shares and up to $210 million earnout, will close in early 2027 pending regulatory approval. This acquisition expands RadNet's services into hospital-based radiology, integrating AI technology with professional services to improve diagnostic imaging workflows and patient care. ONRAD's high-margin, capital-light platform supports over 225 hospitals and is expected to add $190-$200 million in revenue and $60-$65 million in adjusted EBITDA in the first year.

RadNet's acquisition of ONRAD is presented here alongside Pluang's Health-sector market data as of Oct 27, 2026 01:32 WIB. Among 150 Health-sector US stocks, 66 rose and 84 fell today. Twist Bioscience Corp (TWST) gained 3.78% with 100% sell orders and a 27-day typical hold time, contrasting with Tango Therapeutics Inc. (TNGX), which dropped 3.49% despite 86% buy orders and a much shorter 2-day hold time. Amneal Pharmaceuticals Inc. (AMRX) also rose 3.51% with an 18-day hold time.

More News

Exodus Movement to announce Q3 2026 financial results on Nov 9 with a webcast.

Exodus Movement to announce Q3 2026 financial results on Nov 9 with a webcast.

Exodus Movement, a self-custodial finance and payments platform, will release its third quarter 2026 financial results after market close on November 9, 2026. The company will host a webcast at 5:00 PM ET the same day to discuss the results. Founded ...

Company Fundamentals
Neutral
1 hour ago
Onco360 named national pharmacy partner for AstraZeneca's lung cancer drug Zegfrovy.

Onco360 named national pharmacy partner for AstraZeneca's lung cancer drug Zegfrovy.

Onco360, a leading independent specialty pharmacy, has been selected by AstraZeneca as a national pharmacy partner for Zegfrovy (sunvozertinib), a treatment for advanced non-small cell lung cancer with EGFR exon 20 insertion mutations. Zegfrovy has s...

Market News
Bullish
1 hour ago
S4A IT Solutions joins SAP PartnerEdge program, boosting its SAP consulting capabilities.

S4A IT Solutions joins SAP PartnerEdge program, boosting its SAP consulting capabilities.

S4A IT Solutions has been accepted into the SAP PartnerEdge program, marking a key milestone in its growth. This partnership enhances S4A's ability to help organizations maximize their SAP investments, especially in areas like asset management and su...

Market News
Bullish
1 hour ago
SEC policy shifts and rising shareholder activism shape 2027 proxy season preparations for public companies

SEC policy shifts and rising shareholder activism shape 2027 proxy season preparations for public companies

Public companies are facing new challenges for the 2027 proxy season due to changes in SEC policies, evolving shareholder activism strategies, and shifts in institutional investor voting. A virtual roundtable on October 28 will gather experts to disc...

Market News
Neutral
3 hours ago
Gogo to release Q3 2026 earnings on Nov 6 with a conference call for analysts.

Gogo to release Q3 2026 earnings on Nov 6 with a conference call for analysts.

Gogo Inc., a leading provider of in-flight broadband connectivity, announced it will report its third quarter 2026 financial results on November 6, 2026, before the market opens. The company will hold a conference call with financial analysts the sam...

Company Fundamentals
Neutral
3 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App